Alexandre Harari

22PUBLICATIONS
127CO-AUTHORS
Tumour immunologyMolecular targetsCellular nervous systemCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Oct 20, 2025
Targeting SALL4 with an HLA Class I-Restricted TCR for Cancer Immunotherapy.

Myriam Ben Khelil, Maxime Fredon, Nawfel Adib

|Sep 29, 2025
Neuron-reactive KIR+CD8+ T cells display an encephalitogenic transcriptional program in autoimmune encephalitis.

Sylvain Perriot, Samuel Jones, Raphaël Genolet

|Jun 27, 2025
Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer.

Margaux Saillard, Mara Cenerenti, Patrick Reichenbach

|Jun 11, 2025
Phage display enables machine learning discovery of cancer antigen-specific TCRs.

Giancarlo Croce, Rachid Lani, Delphine Tardivon

|Oct 11, 2024
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy.

Florian Huber, Marion Arnaud, Brian J Stevenson

Pageof 4